SG11201808214TA - Pyrazolopyrimidine derivatives - Google Patents
Pyrazolopyrimidine derivativesInfo
- Publication number
- SG11201808214TA SG11201808214TA SG11201808214TA SG11201808214TA SG11201808214TA SG 11201808214T A SG11201808214T A SG 11201808214TA SG 11201808214T A SG11201808214T A SG 11201808214TA SG 11201808214T A SG11201808214T A SG 11201808214TA SG 11201808214T A SG11201808214T A SG 11201808214TA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- str
- compounds
- köln
- leverkusen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16165572 | 2016-04-15 | ||
| PCT/EP2017/058519 WO2017178416A1 (en) | 2016-04-15 | 2017-04-10 | Pyrazolopyrimidine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201808214TA true SG11201808214TA (en) | 2018-10-30 |
Family
ID=55755480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201808214TA SG11201808214TA (en) | 2016-04-15 | 2017-04-10 | Pyrazolopyrimidine derivatives |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US10604525B2 (zh) |
| EP (1) | EP3442974B8 (zh) |
| JP (1) | JP7051703B2 (zh) |
| KR (1) | KR102467347B1 (zh) |
| CN (1) | CN109071545B (zh) |
| AR (1) | AR108130A1 (zh) |
| AU (1) | AU2017251155B2 (zh) |
| CA (1) | CA3020793C (zh) |
| CL (1) | CL2018002920A1 (zh) |
| CO (1) | CO2018010966A2 (zh) |
| DO (1) | DOP2018000226A (zh) |
| ES (1) | ES2953467T3 (zh) |
| IL (1) | IL261885A (zh) |
| MX (1) | MX2018012544A (zh) |
| PH (1) | PH12018550173A1 (zh) |
| PL (1) | PL3442974T3 (zh) |
| RU (1) | RU2769448C2 (zh) |
| SG (1) | SG11201808214TA (zh) |
| TW (1) | TWI742067B (zh) |
| UY (1) | UY37201A (zh) |
| WO (1) | WO2017178416A1 (zh) |
| ZA (1) | ZA201807656B (zh) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201808214TA (en) | 2016-04-15 | 2018-10-30 | Bayer Animal Health Gmbh | Pyrazolopyrimidine derivatives |
| PL3442972T3 (pl) | 2016-04-15 | 2020-07-27 | Abbvie Inc. | Inhibitory bromodomeny |
| AU2018254577B2 (en) | 2017-04-21 | 2024-06-13 | Epizyme, Inc. | Combination therapies with EHMT2 inhibitors |
| AU2018257582B2 (en) * | 2017-04-27 | 2022-06-16 | Bayer Animal Health Gmbh | New bicyclic pyrazole derivatives |
| MA50256A (fr) | 2017-09-15 | 2020-07-22 | Aduro Biotech Inc | Composés de pyrazolopyrimidinone et leurs utilisations |
| IL275339B2 (en) | 2017-12-15 | 2024-03-01 | Tarsus Pharmaceuticals Inc | Parasitic formulations containing isoxazoline and methods for treating blepharitis |
| US20220048903A1 (en) * | 2018-07-09 | 2022-02-17 | Boehringer Ingelheim Animal Health USA Inc. | Anthelminthic Heterocyclic Compounds |
| EP3643711A1 (en) | 2018-10-24 | 2020-04-29 | Bayer Animal Health GmbH | New anthelmintic compounds |
| CA3122106C (en) * | 2018-12-18 | 2024-05-28 | Elanco Tiergesundheit Ag | Bicyclic derivatives |
| CN113474044A (zh) * | 2018-12-18 | 2021-10-01 | 瑞士伊兰科动物保健有限公司 | 双环衍生物 |
| WO2020191091A1 (en) | 2019-03-19 | 2020-09-24 | Boehringer Ingelheim Animal Health USA Inc. | Anthelmintic aza-benzothiophene and aza-benzofuran compounds |
| CN114206860A (zh) * | 2019-06-07 | 2022-03-18 | 礼蓝动物保健有限公司 | 用于治疗体内寄生虫的双环衍生物 |
| TW202120490A (zh) * | 2019-07-30 | 2021-06-01 | 德商拜耳動物保健有限公司 | 新穎異喹啉衍生物 |
| AU2020404100A1 (en) | 2019-12-18 | 2022-06-09 | Intervet International B.V. | Anthelmintic compounds comprising azaindoles structure |
| BR112022024156A2 (pt) | 2020-05-29 | 2023-02-14 | Boehringer Ingelheim Animal Health Usa Inc | Compostos heterocílicos antelmínticos |
| WO2022106469A2 (en) | 2020-11-18 | 2022-05-27 | Elanco Tiergesundheit Ag | N-(2,3-dihydro-1,4-benzoxazin-4-yl)-3-isopropyl-7-(2,3,5-trifluorophenyl)benzo-thiophene-2-carboxamide derivatives and similar compounds for the treatment of heartworm infections |
| TW202237600A (zh) | 2020-12-04 | 2022-10-01 | 瑞士商禮藍動物保健股份有限公司 | 雙環衍生物 |
| CA3203279A1 (en) | 2020-12-11 | 2022-06-16 | Intervet International B.V. | Anthelmintic compounds comprising a thienopyridine structure |
| CN113252824B (zh) * | 2021-06-17 | 2022-04-19 | 湖南农业大学 | 测定水体中三氟苯嘧啶含量的气相色谱-电子捕获检测器法 |
| KR102660894B1 (ko) * | 2021-09-17 | 2024-04-26 | 기초과학연구원 | 피리미딘-2-아민 화합물의 제조방법 |
| AU2022377394A1 (en) | 2021-11-01 | 2024-06-13 | Boehringer Ingelheim Vetmedica Gmbh | Anthelmintic pyrrolopyridazine compounds |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY125533A (en) * | 1999-12-06 | 2006-08-30 | Bristol Myers Squibb Co | Heterocyclic dihydropyrimidine compounds |
| RU15525U1 (ru) | 2000-07-04 | 2000-10-20 | Федеральный научно-производственный центр закрытое акционерное общество "Научно-производственный концерн (объединение) "ЭНЕРГИЯ" | Электродвигатель постоянного тока |
| MXPA04010441A (es) * | 2002-04-23 | 2005-02-14 | Shionogi & Co | Derivado de pirazolo[1,5-a]pirimidina e inhibidor de nad(p)h oxidasa que contiene el mismo. |
| GB0213715D0 (en) | 2002-06-14 | 2002-07-24 | Syngenta Ltd | Chemical compounds |
| TWI312272B (en) | 2003-05-12 | 2009-07-21 | Sumitomo Chemical Co | Pyrimidine compound and pests controlling composition containing the same |
| EA009517B1 (ru) * | 2003-06-27 | 2008-02-28 | Байер Кропсайенс Аг | Пиразолопиримидины |
| AU2004251845A1 (en) | 2003-06-27 | 2005-01-06 | Bayer Cropscience Aktiengesellschaft | Pyrazolopyrimidines |
| GB0414438D0 (en) | 2004-06-28 | 2004-07-28 | Syngenta Participations Ag | Chemical compounds |
| WO2006043635A1 (ja) | 2004-10-20 | 2006-04-27 | Kumiai Chemical Industry Co., Ltd. | ３－トリアゾリルフェニルスルフィド誘導体及びそれを有効成分として含有する殺虫・殺ダニ・殺線虫剤 |
| BRPI0616839A2 (pt) | 2005-10-06 | 2013-01-01 | Nippon Soda Co | agentes para controle de praga, e, compostos de amina cìclicos |
| EP1918291A1 (en) * | 2006-10-30 | 2008-05-07 | Novartis AG | 3-Aminocarbonyl-substituted fused pyrazolo-derivatives as protein kinase modulators |
| EP2102211A2 (en) * | 2006-11-20 | 2009-09-23 | Alantos Pharmaceuticals Holding, Inc. | Heterobicyclic metalloprotease inhibitors |
| JP5372763B2 (ja) | 2007-09-28 | 2013-12-18 | 協和発酵キリン株式会社 | 皮膚疾患の予防及び／または治療剤 |
| JP5268461B2 (ja) | 2008-07-14 | 2013-08-21 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | Ｐｆ１３６４物質、その製造方法、生産菌株、及び、それを有効成分とする農園芸用殺虫剤 |
| CN101337937B (zh) | 2008-08-12 | 2010-12-22 | 国家农药创制工程技术研究中心 | 具有杀虫活性的n-苯基-5-取代氨基吡唑类化合物 |
| CN101337940B (zh) | 2008-08-12 | 2012-05-02 | 国家农药创制工程技术研究中心 | 具杀虫活性的含氮杂环二氯烯丙醚类化合物 |
| CN101715774A (zh) | 2008-10-09 | 2010-06-02 | 浙江化工科技集团有限公司 | 一个具有杀虫活性化合物制备及用途 |
| EP2184273A1 (de) | 2008-11-05 | 2010-05-12 | Bayer CropScience AG | Halogen-substituierte Verbindungen als Pestizide |
| GB0820344D0 (en) | 2008-11-06 | 2008-12-17 | Syngenta Ltd | Herbicidal compositions |
| US8007468B2 (en) | 2009-07-13 | 2011-08-30 | Navilyst Medical, Inc. | Method to secure an elastic component in a valve |
| WO2011085575A1 (zh) | 2010-01-15 | 2011-07-21 | 江苏省农药研究所股份有限公司 | 邻杂环甲酰苯胺类化合物及其合成方法和应用 |
| UA109149C2 (xx) | 2010-08-31 | 2015-07-27 | Засіб боротьби зі шкідниками | |
| CN101967139B (zh) | 2010-09-14 | 2013-06-05 | 中化蓝天集团有限公司 | 一种含一氟甲氧基吡唑的邻甲酰氨基苯甲酰胺类化合物、其合成方法及应用 |
| WO2012112363A1 (en) | 2011-02-14 | 2012-08-23 | Merck Sharp & Dohme Corp. | Cathepsin cysteine protease inhibitors |
| WO2013050317A1 (en) | 2011-10-03 | 2013-04-11 | Syngenta Limited | Polymorphs of an isoxazoline derivative |
| CN102391261A (zh) | 2011-10-14 | 2012-03-28 | 上海交通大学 | 一种n-取代噁二嗪类化合物及其制备方法和应用 |
| ES2626360T3 (es) | 2012-03-30 | 2017-07-24 | Basf Se | Compuestos de piridinilideno tiocarbonilo N-sustituidos y su uso para combatir plagas de animales |
| EP2647626A1 (en) | 2012-04-03 | 2013-10-09 | Syngenta Participations AG. | 1-Aza-spiro[4.5]dec-3-ene and 1,8-diaza-spiro[4.5]dec-3-ene derivatives as pesticides |
| JP6463670B2 (ja) | 2012-04-27 | 2019-02-06 | ダウ アグロサイエンシィズ エルエルシー | 農薬組成物およびそれらに関する方法 |
| US9282739B2 (en) | 2012-04-27 | 2016-03-15 | Dow Agrosciences Llc | Pesticidal compositions and processes related thereto |
| EP2914591B1 (en) | 2012-11-03 | 2017-10-11 | Boehringer Ingelheim International GmbH | Inhibitors of cytomegalovirus |
| CN103232431B (zh) | 2013-01-25 | 2014-11-05 | 青岛科技大学 | 一种二卤代吡唑酰胺类化合物及其应用 |
| CN103109816B (zh) | 2013-01-25 | 2014-09-10 | 青岛科技大学 | 硫代苯甲酰胺类化合物及其应用 |
| WO2014158644A1 (en) | 2013-03-13 | 2014-10-02 | Dow Agrosciences Llc | Process for the preparation of triaryl rhamnose carbamates |
| CN103265527B (zh) | 2013-06-07 | 2014-08-13 | 江苏省农用激素工程技术研究中心有限公司 | 邻氨基苯甲酰胺化合物及其制备方法和应用 |
| CN103524422B (zh) | 2013-10-11 | 2015-05-27 | 中国农业科学院植物保护研究所 | 苯并咪唑衍生物及其制备方法和用途 |
| US9102654B2 (en) | 2013-10-17 | 2015-08-11 | Dow Agrosciences Llc | Processes for the preparation of pesticidal compounds |
| US9108946B2 (en) | 2013-10-17 | 2015-08-18 | Dow Agrosciences Llc | Processes for the preparation of pesticidal compounds |
| UY36196A (es) * | 2014-07-25 | 2016-02-29 | Bayer Animal Health Gmbh | Compuestos para usar en el tratamiento antihelmíntico |
| SG11201808214TA (en) | 2016-04-15 | 2018-10-30 | Bayer Animal Health Gmbh | Pyrazolopyrimidine derivatives |
-
2017
- 2017-04-10 SG SG11201808214TA patent/SG11201808214TA/en unknown
- 2017-04-10 RU RU2018140092A patent/RU2769448C2/ru active
- 2017-04-10 JP JP2018553486A patent/JP7051703B2/ja active Active
- 2017-04-10 CN CN201780023855.8A patent/CN109071545B/zh active Active
- 2017-04-10 WO PCT/EP2017/058519 patent/WO2017178416A1/en active Application Filing
- 2017-04-10 AU AU2017251155A patent/AU2017251155B2/en active Active
- 2017-04-10 ES ES17715204T patent/ES2953467T3/es active Active
- 2017-04-10 CA CA3020793A patent/CA3020793C/en active Active
- 2017-04-10 US US16/093,565 patent/US10604525B2/en active Active
- 2017-04-10 MX MX2018012544A patent/MX2018012544A/es unknown
- 2017-04-10 PL PL17715204.8T patent/PL3442974T3/pl unknown
- 2017-04-10 EP EP17715204.8A patent/EP3442974B8/en active Active
- 2017-04-10 KR KR1020187032684A patent/KR102467347B1/ko active IP Right Grant
- 2017-04-12 AR ARP170100939A patent/AR108130A1/es unknown
- 2017-04-13 TW TW106112313A patent/TWI742067B/zh active
- 2017-04-18 UY UY0001037201A patent/UY37201A/es not_active Application Discontinuation
-
2018
- 2018-09-20 IL IL261885A patent/IL261885A/en unknown
- 2018-10-12 DO DO2018000226A patent/DOP2018000226A/es unknown
- 2018-10-12 CO CONC2018/0010966A patent/CO2018010966A2/es unknown
- 2018-10-12 CL CL2018002920A patent/CL2018002920A1/es unknown
- 2018-10-15 PH PH12018550173A patent/PH12018550173A1/en unknown
- 2018-11-14 ZA ZA2018/07656A patent/ZA201807656B/en unknown
-
2020
- 2020-01-29 US US16/776,374 patent/US11001590B2/en active Active
- 2020-01-29 US US16/776,377 patent/US10934301B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201808214TA (en) | Pyrazolopyrimidine derivatives | |
| SG11201903059SA (en) | New anthelmintic quinoline-3-carboxamide derivatives | |
| SG11202000266VA (en) | Quinoline derivatives for treating infections with helminths | |
| SG11201909243TA (en) | New bicyclic pyrazole derivatives | |
| SG11201908547VA (en) | Hydrogel cross-linked hyaluronic acid prodrug compositions and methods | |
| SG11201906297QA (en) | Nucleic acids encoding crispr-associated proteins and uses thereof | |
| SG11201810366WA (en) | 3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides | |
| SG11201805940QA (en) | Benzopyrazole compounds and analogues thereof | |
| SG11201906436VA (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
| SG11201808108XA (en) | Synthesis of indazoles | |
| SG11201907604UA (en) | Crystalline forms of the 4-pyrimidinesulfamide derivative aprocitentan | |
| SG11201900021PA (en) | Methods and compositions for the treatment of cancer | |
| SG11201808231VA (en) | Delivery system | |
| SG11201808686VA (en) | Synthesis of indazoles | |
| SG11201902531QA (en) | Liquid pharmaceutical composition | |
| SG11201901817SA (en) | Blood-brain barrier-penetrant dopamine-b-hydroxylase inhibitors | |
| SG11201810371XA (en) | ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF | |
| SG11201408617PA (en) | Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and cns disorders | |
| SG11201811230RA (en) | Compositions and methods for reducing ocular neovascularization | |
| SG11201901534VA (en) | Combination therapy with controlled-release cnp agonists | |
| SG11201803915UA (en) | Echinomycin formulation, method of making and method of use thereof | |
| SG11201806393QA (en) | Use of gabaa receptor modulators for treatment of itch | |
| SG11201903061YA (en) | Combination treatments comprising administration of imidazopyrazinones | |
| SG11201407575PA (en) | 5-amino[1,4]thiazines as bace 1 inhibitors | |
| SG11201908065YA (en) | Deuterated imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer |